Open Now: The Global ETF Survey Take the Survey →

Advertisement
Advertisement

FXHvsXLVETF Comparison

ETF 1
FXH

First Trust Health Care AlphaDEX Fund ETF

This fund is part of
US Health Care
+0.53%
VS
ETF 2
XLV

State Street Health Care Select Sector SPDR ETF

This fund is part of
US Health Care
+0.53%

First Trust Health Care AlphaDEX Fund ETF (FXH) and State Street Health Care Select Sector SPDR ETF (XLV) belong to the same industry segment: US Health Care. FXH's top 1 sector exposures are Healthcare. In contrast, XLV's top sector exposures are Healthcare and Consumer Non-Cyclicals. FXH is more expensive with a Total Expense Ratio (TER) of 0.61%, versus 0.08% for XLV. FXH is up 13.36% year-to-date (YTD) with +$32M in YTD flows. XLV performs worse with 5.57% YTD performance, and +$419M in YTD flows. Run a side-by-side ETF comparison of FXH and XLV below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

FXH vs XLV performance and flow charts

Performance

-3.0-2.0-1.00.01.02.03.0%Jul 6Jul 13Jul 20Jul 27Aug 3

Cumulative Flows

0 M200 M400 M600 M800 MJul 6Jul 13Jul 20Jul 27Aug 3

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 08/04/2026
1M3MYTD1Y3Y5Y
Perf.
FXH
XLV
+2.38%+0.02%
+14.38%+12.42%
+13.36%+5.57%
+29.25%+23.92%
+24.97%+28.71%
+5.83%+31.47%
Flows
FXH
XLV
+$57M+$190M
+$88M-$272M
+$32M+$419M
+$1M+$2.05B
-$594M-$4.88B
-$464M+$2.37B
Volatility and drawdown
3M1Y3Y5Y
Volatility
FXH
XLV
+15.84%+18.49%
+15.82%+15.60%
+15.52%+14.42%
+16.88%+15.01%
Max drawdown
FXH
XLV
-3.81%-3.83%
-12.07%-10.51%
-17.66%-17.05%
-29.40%-17.05%
Max drawdown duration
FXH
XLV
20d20d
168d116d
395d444d
1759d444d
Trading data

Create an account to view trading data

Join for free
FXH
XLV
Last sale
8/5/2026 at 1:30 PM
$128.30
$164.15
Previous close
08/04/2026
$128.40
$162.10
Consolidated volume
08/04/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of July 31, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

Create an account to view replication quality

Join for free
FXH
XLV
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 8/5/2026 at 1:30 PM
Live
Closed
FXH
XLV
Last price
$128.30
$164.15
1D performance
-0.08%
+1.26%
AuM$1.09 B$41.87 B
E/R0.61%0.08%
Characteristics
FXH
XLV
Management strategyPassivePassive
ProviderFirst TrustState Street Investment Management
BenchmarkStrataQuant Health Care IndexS&P Health Care Select Sector Index
N° of holdings7559
Asset classEquitiesEquities
Trailing 12m distribution yield
Join
Join
Inception dateMay 8, 2007December 16, 1998
ESGNoNo
Advertisement
Exposure

Countries

FXH
USA
96.02%
Other
3.98%
XLV
USA
97.92%
Other
2.08%

Sectors

FXH
Healthcare
99.85%
Other
0.15%
XLV
Healthcare
97.73%
Other
2.27%
Advertisement

Diversification

FXH

Total weight of top 15 holdings out of 15

38.89%
XLV

Total weight of top 15 holdings out of 15

72.82%

Top 15 holdings

Data as of June 30, 2026
FXH
Humana, Inc.
4.74%
Organon & Co.
3.63%
DaVita, Inc.
2.98%
Elevance Health, Inc.
2.86%
Molina Healthcare, Inc.
2.80%
Exelixis, Inc.
2.53%
Incyte Corp.
2.43%
Solventum Corp.
2.41%
Biogen, Inc.
2.30%
Cardinal Health, Inc.
2.26%
Bio-Rad Laboratories, Inc.
2.14%
The Cigna Group
2.09%
Chemed Corp.
2.05%
Zimmer Biomet Holdings, Inc.
1.87%
Illumina, Inc.
1.80%
XLV
Eli Lilly & Co.
16.57%
Johnson & Johnson
10.68%
AbbVie, Inc.
7.76%
UnitedHealth Group, Inc.
6.59%
Merck & Co., Inc.
5.54%
Amgen, Inc.
3.41%
Thermo Fisher Scientific, Inc.
3.25%
Abbott Laboratories
2.76%
Gilead Sciences, Inc.
2.74%
Intuitive Surgical, Inc.
2.46%
Pfizer Inc.
2.40%
CVS Health Corp.
2.31%
Vertex Pharmaceuticals, Inc.
2.20%
Danaher Corp.
2.10%
Bristol Myers Squibb Co.
2.05%
Frequently asked questions about FXH and XLV

How have the FXH and XLV ETFs performed in 2026?

As of August 4, 2026, FXH is up 13.36% year-to-date (YTD), while XLV has returned 5.57%. That puts FXH better performer ahead so far this year.

Which ETF is attracting more investor money: FXH or XLV?

Year-to-date, the FXH ETF saw +$32M in flows, compared to +$419M for XLV.

Which ETF is more volatile: FXH or XLV?

Over the past year, FXH had a volatility of 15.82%, while XLV experienced 15.6%.

Which ETF is bigger: FXH or XLV?

As of August 4, 2026, FXH holds $1.09 B in assets under management (AUM), while XLV manages $41.87 B.

What sectors do the FXH and XLV ETFs invest in?

FXH leans toward sectors like Healthcare. Meanwhile, XLV focuses on Healthcare.

What are the top holdings of the FXH ETF and XLV ETF?

FXH top holdings include Humana, Inc., Organon & Co. and DaVita, Inc.. XLV holds in its top three: Eli Lilly & Co., Johnson & Johnson and AbbVie, Inc..

Which ETF is more diversified: FXH or XLV?

FXH holds 75 securities with 38.89% of its assets in the top 15. XLV has 59 securities and a top 15 weight of 72.82%.

Advertisement
Advertisement
Advertisement
The Active Trader Report

Active Trader Report: Use of Leveraged & Inverse ETFs Way Up

Direxion partnered with Compound Insights and Vanda to explore what’s driving the evolution of active trading — and how active traders are using leveraged and inverse funds across equities, single stocks, commodities, and volatility.

Active Trader Report: Use of Leveraged & Inverse ETFs Way Up